The artificial cervical intervertebral disc market size is expected to grow from US$ 1,621. 66 million in 2022 to US$ 4,375. 29 million by 2028; it is estimated to grow at a CAGR of 18. 0% from 2022 to 2028.
New York, July 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Artificial Cervical Intervertebral Disc Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Material, End User, and Geography" - https://www.reportlinker.com/p06289883/?utm_source=GNW The market growth is attributed to the increasing cases of cervical injuries and a surge in the aging population. However, the high cost of cervical intervertebral disc surgeries hampers the artificial cervical intervertebral disc market growth. The aging process affects the cervical spine, neck, shoulders, upper back, and arms.Cervical spondylosis is a term for age-related wear and tear of the spinal disks in the neck; the condition worsens with age. As per the American Academy of Orthopaedic Surgeons, over 85% of people of age more than 60 are affected by cervical spondylosis.With age, the vertebral discs that serve as shock absorbers gradually dry out and affect the strength of the disc. As per the Factsheet, the number of Americans aged 65 and older in 2018 is estimated to double from 52 million to 95 million by 2060.It is also estimated that the 65-and-older age groups will rise from 16% to 23%. Further, as per the report ‘Later Life in the UK 2019 - Age UK’, around 12 million (11,989,322) people aged 65 and above in the UK, of which 5.4 million people are aged 75 years or more, and 1.6 million are aged 85 years of old. Additionally, Japan is another aging nation and called ’super-aged’ society, with 28.7 % of its population being 65 or older. Thus, the growing aging population is likely to increase the demand for artificial cervical intervertebral discs. Companies in the artificial cervical intervertebral disc market are undertaking many research and development activities to introduce innovative products.The new replacement therapies enable the adoption of advanced technologies, strengthening the procedural outcomes. For instance, in April 2021, US Food and Drug Administration (FDA) approved NuVasive Simplify Cervical Artificial Disc for two-level cervical total disc replacement (cTDR). Additionally, in August 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, received US FDA approval for its M6-C artificial cervical disc. The M6-C artificial cervical disc, a next-generation artificial disc, is developed to replace an intervertebral disc damaged by cervical disc degeneration, further restoring the physiological motion of the spine. Moreover, in May 2018, Zimmer Biomet received approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for its Mobi-C Cervical Disc for cTDR. Mobi-C is the first cervical disc prosthesis approved by the US FDA to reconstruct a cervical disc at one and two levels (C3-C7). Such robust developments reshape the artificial cervical intervertebral disc market. With increasing manufacturing costs, medical device manufacturers struggle to generate enough revenue to please their investors.The emerging markets in developing economies are crucial in offering better and more lucrative growth opportunities to major players to expand their business and geographic reach. The treatment of orthopedic conditions has become simpler with the help of advanced medical technologies.Minimally invasive surgeries such as artificial cervical intervertebral disc replacement surgery have reduced the consumption of heavy-dose medicines. The adoption of these orthopedic surgeries is likely to increase in emerging regions, such as Asia Pacific and the Middle East & Africa.These regions invest more in the healthcare sector and aggressively create awareness regarding minimally invasive orthopedic surgeries. The growing healthcare expenditure in economies such as India, China, and the UAE creates notable opportunities. These countries are witnessing an increase in adult and geriatric populations. Therefore, the incidences of orthopedic conditions are likely to increase. Also, there is a rise in the number of start-up companies operating in healthcare sectors in India, China, etc. In addition, the availability of technologically advanced infrastructure is likely to boost the local players in the manufacturing of advanced orthopedic products. Therefore, the market in developing countries is likely to show high growth potential. End User Insights The artificial cervical intervertebral disc market is segmented on the basis of material and end user.Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2022, the hospitals segment is likely to hold the largest share of the market.The hospital provides healthcare facilities through specialized scientific equipment. Various medical research team constantly works on introduction of innovative technologies related to the treatment methods in the medical field.Most of the surgeries are performed in hospitals, owing to continuous patient care and monitoring. Also, growing government funding for hospitals and rising hospitalization of patients drives market growth. However, the ambulatory surgical center is expected to report the fastest CAGR of 18.5% during 2022–2028. Ambulatory surgical center (ASC) also known as outpatient care center is healthcare facility that provides outpatient services like diagnosis, treatment, consultation, and intervention services. These offer wide range of medical services like lab services, imaging modalities, observation beds and many more. ASCs offer cost-effective services and a convenient environment which is less stressful than many hospitals. Patients in ambulatory surgical centers generally opt for one day procedure, have their surgery in advanced operating room and recover under the care of highly skilled healthcare professionals, without getting hospital admission. Thus, owing high quality care, cost effective treatment prices, and expanding access is likely to favor the growth of the segment. The Centers for Disease Control and Prevention, Association of Indian Medical Device Industry, Australian Institute of Health and Welfare, German Arthroplasty Registry, and the Hindustan Syringes and Medical Devices are among the primary and secondary sources referred to while preparing the report on the artificial cervical intervertebral disc market. Read the full report: https://www.reportlinker.com/p06289883/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
SIGA Technologies, maker of the only available monkeypox treatment, is working to ramp up manufacturing for broader global distribution.
We just can't get a break from COVID. While things were inching closer towards normalcy, cases are rising again thanks to the latest dominant variant BA.5, which experts say is the most contagious COVID strain yet. Although the virus affects everyone differently, there are symptoms to watch out for that indicate you've had COVID and Eat This, Not That! Health spoke with Dr. Mark Fischer, Regional Medical Director at International SOS who explains what to know about BA.5 and symptoms to watch out
Whether you're nursing a cold or need a quick and easy lunch, soup is the one food that practically everyone has in their pantry. No matter much or little you know about cooking, being able to grab your can opener or tear into a packet for a reliably good meal is a convenience that's too good for most to pass up—especially if you haven't had time to make it to the grocery store for fresh ingredients lately. But now, the Food&Drug Administration (FDA) is warning consumers that one soup that may b
A Copenhagen company worked for nearly two decades to develop a vaccine and only six governments bought it. Bavarian Nordic A/S is the world’s sole supplier of a licensed vaccine for monkeypox. The World Health Organization in recent days declared the disease a public health emergency of international concern, the first time the group has issued that designation since the early days of the Covid-19 pandemic.
'We need vaccines with longer duration and greater breadth of protection,' said Dr. David Kessler, chief science officer for the White House’s COVID-19 response team.
The highly contagious BA.5 subvariant is causing a nationwide spike in cases, and experts believe the numbers might actually be higher thanks to at-home testing. But even without accurate data, there is no doubt a surge is happening. "You don't have to count every raindrop to know it's raining," says Dr. Joseph Kanter, Louisiana's state health officer and medical director. "And it's pouring right now." Here are five signs of BA.5 that are easy to miss, according to experts. Read on—and to ensure
We all know the feeling—standing there in the bread aisle at the grocery store, craving a delicious sandwich or slice of toast, while simultaneously telling ourselves that we can't buy any bread because it's "unhealthy."But why do we so often force ourselves to avoid bread when in reality bread isn't the enemy? We've been told for so long that in order to be healthy we have to avoid carbs, but giving up bread completely may mean you'll lose out on valuable nutrients.The main distinction to note
A federal court ruling has dealt a blow to Bausch Health by appearing to clear the way for generic competition for the company’s drug Xifaxan. Bausch Health stock (ticker: BHC) plummeted more than 50% Thursday morning on the news, and trading of the shares was halted. In 2020, Bausch Health Ireland and Salix Pharmaceuticals sued Norwich Pharmaceuticals in 2020 for patent infringement, regarding Norwich’s plans to bring a generic version of Xifaxan to market before its patents had expired, according to a Bloomberg Law report.
Monkeypox has spread across multiple countries, including the U.S., where the Centers for Disease Control and Prevention (CDC) has confirmed almost 5,000 cases since May. While reminiscent of the beginning of the COVID-19 pandemic, this viral disease spreads differently. We all remember masking up, wearing gloves, and waiting in line to get into the grocery store in 2020, but will we have to do that again because of this virus?Experts at the CDC and others say monkeypox spreads mostly through cl
The 300 vaccines that were allocated for DeKalb County are already spoken for.
We are in an epidemic of stress right now, and ashwagandha is an adaptogenic that helps our bodies become more resilient to stress, says Robin Foroutan, RDN.
AstraZeneca's Covid-19 antibody drug slashes the risk of new variants emerging, the company said, as Britain faces mounting pressure to follow other Western nations in ordering doses.
U.S. regulators said Friday they are no longer considering authorizing a second COVID-19 booster shot for all adults under 50 this summer, focusing instead on revamped vaccines for the fall that will target the newest viral subvariants. Pfizer and Moderna expect to have updated versions of their shots available as early as September, the Food and Drug Administration said in a statement. The announcement means the U.S. won’t pursue a summer round of boosters using the current vaccines for adults under 50, as some Biden administration officials and outside experts previously suggested.
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?
The sharpest opinions on the debate from around the web
With growing concerns that the monkeypox outbreak could turn into another pandemic, local health offices have been flooded with requests for the monkeypox vaccine. According to the Centers for Disease Control and Prevention, there have been just 330 cases here in Georgia as of July 29.
The company had said it was in talks with the FDA about seeking early approval, but Wall Street analysts thought the agency would make it wait to apply.
A once-prominent neurologist was found guilty Friday on charges of sexually abusing patients while treating them with pain medications. A New York City jury reached the verdict after deliberating for about three days at the trial of Dr. Ricardo Cruciani. Cruciani, 68, was convicted on 12 criminal counts — one count of predatory sexual assault, one of attempted rape, one of sex abuse, two of rape and seven of criminal sexual acts.
Strong quarterly sales of Pfizer’s Covid-19 products helped offset mixed results from other products, and the drugmaker sees full-year revenue gains being offset by unfavorable currency effects.
Compared with the earlier Omicron BA.2 subvariant, currently dominant Omicron BA.5 is linked with higher odds of causing a second SARS-COV-2 infection regardless of vaccination status, a study from Portugal suggests. Further, they found, in infected heart muscle cells only the SARS-CoV-2 spike interacted with so-called TLR4 proteins (Toll-like receptor-4) that recognize invaders and trigger inflammatory responses.